China approves first domestic mRNA vaccine for Covid-19 / Photo: GREG BAKER - AFP/File
-
US tariff and inflation fears rattle global markets
-
Thousands flee as Los Angeles wildfires burn out of control
-
Spanish PM says Musk 'stirs up hatred', warns against fascism
-
Bournemouth striker Unal tears ACL in training session
-
US private sector hiring undershoots expectations: ADP
-
Arteta mocked by League Cup organisers after 'tricky' ball excuse
-
US tariffs unlikely to have 'significant' inflation impact: Fed official
-
Debris falling from the sky: more often, more risk
-
Lebanon leaders in talks for new bid to elect president
-
Antarctic sea ice rebounds from record lows: US scientists
-
Can EU stand up to belligerent Big Tech in new Trump era?
-
France goalkeeper Samba joins Rennes
-
Global stocks diverge on renewed US inflation fears
-
France coach Deschamps to step down after 2026 World Cup
-
French magazine run by autistic journalists hits newsstands
-
US, Canadian and Australian travellers now face UK entry fee
-
France urges European Commission to be firm against Musk interference
-
Wildfire sparks panicked evacuations in Los Angeles suburbs
-
Nobel winner Ressa tells AFP 'dangerous times' ahead after Meta ends US fact-checking
-
Indonesia upholds iPhone 16 sales ban after Apple offers $1 bn investment
-
Dutch great Kluivert named Indonesia coach in hunt for World Cup spot
-
UK's Catherine turns 43 hoping for better year
-
France coach Deschamps says will leave after 2026 World Cup
-
South Syria fighters reluctant to give up weapons: spokesman
-
Dutch great Kluivert named coach of Indonesia
-
New Zealand crush Sri Lanka by 113 runs in 2nd ODI to win series
-
West Ham cancel Lopetegui press conference as sacking rumours swirl
-
Questions remain over South African involvement in Champions Cup
-
OpenAI chief Sam Altman denies sister's sexual abuse accusations
-
Hundreds rally for South Korea's Yoon as new arrest bid beckons
-
Bangladesh orders banks to assist UK minister graft probe
-
Germans turn to balcony solar panels to save money
-
Theekshana hat-trick restricts NZ to 255-9 in 2nd Sri Lanka ODI
-
Young's buzzer-beater lifts Hawks, Celtics down Nuggets
-
Grief and nostalgia in India's 'Jimmy Carter village'
-
Venezuela's 'colectivos' ready to pounce as opposition plans protest
-
Thai police hunt suspect over Cambodian politician shooting
-
Venezuela on tenterhooks ahead of rival protests, Maduro swearing-in
-
Devajit Saikia: lawyer, modest player and next India cricket chief
-
S. Korea's impeached President Yoon holds out in capital 'fortress'
-
Samsung warns fourth-quarter profit to miss forecasts
-
China's viral wild boar hunters attract fame and concern
-
Forgotten but not gone: Covid keeps killing, five years on
-
Is the world ready for the next pandemic?
-
Trump's provocative, often confusing, US foreign policy is back
-
Rescuers search for survivors after quake in China's Tibet kills at least 126
-
Brazil gears up for first climate conference in Amazon
-
In Brazil, an Amazon reforestation project seeks to redeem carbon markets
-
Djokovic with point to prove against younger rivals at Australian Open
-
Asian markets mixed after Wall St hit by US inflation fears
NYSE - LSE
| RYCEF | -0.42% | 7.17 | $ | |
| CMSC | -0.3% | 23.16 | $ | |
| RELX | 1% | 46.445 | $ | |
| GSK | -1.7% | 33.519 | $ | |
| SCS | -1.17% | 11.07 | $ | |
| NGG | -2.34% | 57.26 | $ | |
| RBGPF | -4.54% | 59.31 | $ | |
| RIO | -0.02% | 58.18 | $ | |
| BTI | -1.04% | 36.401 | $ | |
| VOD | -3.38% | 8.135 | $ | |
| AZN | -0.98% | 65.99 | $ | |
| CMSD | -0.43% | 23.36 | $ | |
| BCE | -1.51% | 23.505 | $ | |
| BCC | -1.81% | 116.12 | $ | |
| BP | -1.79% | 31.27 | $ | |
| JRI | -0.45% | 12.165 | $ |
China approves first domestic mRNA vaccine for Covid-19
China has approved its first locally developed messenger RNA (mRNA) vaccine against Covid-19, its manufacturer said Wednesday, months after the relaxation of strict Covid-zero regulations sparked a surge in cases.
The vaccine, developed by CSPC Pharmaceutical Group Ltd, has been approved for "emergency use" by Beijing's health regulator, the company said in a statement.
It showed high efficacy in a trial in which it was used as a booster shot for people who have been given other types of vaccines, the company added, without offering further details.
mRNA vaccines are considered among the most effective in reducing severe infections and deaths.
While traditional vaccines use a weakened or inactivated germ to prepare the body for a future attack from the real virus, mRNA deploys snippets of genetic material that carry instructions showing the body's cells how to produce a protein -- in this case, the spike protein on the coronavirus that causes Covid.
The body's immune system then triggers antibodies to fight off that spike protein, making it ready for when the real coronavirus comes knocking.
Beijing has refused to greenlight mRNA-based vaccines from foreign firms Pfizer-BioNTech and Moderna for public use.
Its vaccination shortfall was widely believed to have led to more severe infections and deaths after lockdowns and mandatory quarantine rules were suddenly dropped in December.
Other Chinese drugmakers including CanSino have previously said they were developing mRNA-based shots to help the country bridge its immunisation gap.
M.A.Colin--AMWN
